Rearming the body’s immune system to fight cancer

We’re developing more precise and more accessible treatment alternatives for patients with solid cancers

Pioneering excellence in the field of immunotherapy

Cartherics creates precisely-defined immunotherapy treatments to combat a variety of cancers. We combine the best components of immune targeting utilising gene editing and CAR technology to advance cell therapy to provide more diverse off-the-shelf treatments for patients. Our team has strong backgrounds in research, development, and product commercialisation. And we partner with leading commercial and academic groups with complementary technology to push the boundaries of cell therapy for cancer.

Learn more about us

Some of our partners

Latest news

CRC-P Grant, 4th round selection announcement – success for Cartherics.

By carth_admin / July 11, 2018
Cartherics has been advised by the Hon Craig Laundy MP (Assistant Minister for Industry, Innovation and Science) that its application...
Read More

Biotech Daily reports ….. Professor Jacques Miller wins Japan prize, January 2018

By carth_admin / May 31, 2018
Professor Jacques Miller a member of Cartherics’ Scientific Advisory Board  wins “The Japan Prize Foundation says Walter and Eliza Hall...
Read More